© 1996 British Society for Rheumatology
other |
SLICC/ACR DAMAGE INDEX IS VALID, AND RENAL AND PULMONARY ORGAN SCORES ARE PREDICTORS OF SEVERE OUTCOME IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
*Department of Biostatistics, ISPM, University CH-8091 Zürich, Switzerland
Bloomsbury Rheumatology Unit/Division of Rheumatology, Department of Medicine, University College of London London W1P 9PG
Correspondence to:
Correspondence to: T. Stoll, Department of Rheumatology, City Hospital Waid, Tièchestr. 99. CH 8037Zürich, Switzerland.
We investigated the Systemic Lupus International Collaborative Clinics/American College of Rheumatology (SLICC/ACR) Damage Index as a predictor of severe outcome and an indicator of morbidity in different ethnic groups, and in regard to its validity. We retrospectively studied disease course within 10 yr of diagnosis in an inception cohort of 80 patients with systemic lupus erythematosus (SLE). The mean renal damage score (DS) at 1 yr after diagnosis was a significant predictor of endstage renal failure and the mean pulmonary DS at 1 yr significantly predicted death within 10 yr of diagnosis. Compared to Caucasians, Afro-Caribbeans and Asians had significantly higher mean total DS at 5 and 10 yr, and higher mean renal DS at 10 yr. At 5 yr, the mean renal DS in Afro-Caribbeans and the mean neuropsychiatric DS in Asians were significantly higher than in Caucasians. The rate of endstage renal failure in Caucasians was significantly lower than in the other ethnic groups. Our results confirm the validity of the SLICC/ACR Damage Index.
KEY WORDS: SLICC/ACR Damage Index, Death, Endstage renal failure, Morbidity in different ethnic groups, SLE
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Rabbani, H. Habib, M Islam, B Ahmad, S Majid, W Saeed, S. Shah, and A Ahmad Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients Lupus, August 1, 2009; 18(9): 848 - 855. [Abstract] [PDF]
|
|
|
|
 |
|
 S. A. Chambers, E. Allen, A. Rahman, and D. Isenberg Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years Rheumatology, June 1, 2009; 48(6): 673 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Danila, G. J. Pons-Estel, J. Zhang, L. M. Vila, J. D. Reveille, and G. S. Alarcon Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort Rheumatology, May 1, 2009; 48(5): 542 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Y. Zhu, L.-S. Tam, V. W. Y. Lee, K. K. Lee, and E. K. Li Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong Rheumatology, May 1, 2009; 48(5): 564 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Gordon, G Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I-M Gilboe, F Houssiau, et al. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus Ann Rheum Dis, April 1, 2009; 68(4): 470 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cardoso, F. Signorelli, J. Papi, and G. Salles Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study Lupus, November 1, 2008; 17(11): 1042 - 1048. [Abstract] [PDF]
|
|
|
|
 |
|
 O Flossmann, P Bacon, K de Groot, D Jayne, N Rasmussen, P Seo, K Westman, and R Luqmani Development of comprehensive disease assessment in systemic vasculitis Postgrad. Med. J., March 1, 2008; 84(989): 143 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.T. Hiraki, J. Hamilton, and E.D. Silverman Review: Measuring permanent damage in pediatric systemic lupus erythematosus Lupus, August 1, 2007; 16(8): 657 - 662. [Abstract] [PDF]
|
|
|
|
|
|
A.M. Bertoli, L.M. Vila, M. Apte, B.J. Fessler, H.M. Bastian, J.D. Reveille, and G.S. Alarcon Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage Lupus, June 1, 2007; 16(6): 410 - 417. [Abstract] [PDF]
|
|
|
|
|
|
O. Flossmann, P. Bacon, K. de Groot, D. Jayne, N. Rasmussen, P. Seo, K. Westman, and R. Luqmani Development of comprehensive disease assessment in systemic vasculitis Ann Rheum Dis, March 1, 2007; 66(3): 283 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Bernatsky, A Clarke, D D Gladman, M Urowitz, P R Fortin, S G Barr, J-L Senecal, M Zummer, S Edworthy, J Sibley, et al. Mortality related to cerebrovascular disease in systemic lupus erythematosus Lupus, December 1, 2006; 15(12): 835 - 839. [Abstract] [PDF]
|
|
|
|
|
|
C S Lau, G Yin, and M Y Mok Ethnic and geographical differences in systemic lupus erythematosus: an overview Lupus, November 1, 2006; 15(11): 715 - 719. [Abstract] [PDF]
|
|
|
|
|
|
M Bandeira, S Buratti, M Bartoli, C Gasparini, L Breda, A Pistorio, S Grassi, M. Alpigiani, G Barbano, L. Janz-Junior, et al. Relationship between Damage Accrual, Disease Flares and Cumulative Drug Therapies in Juvenile-Onset Systemic Lupus Erythematosus Lupus, August 1, 2006; 15(8): 515 - 520. [Abstract] [PDF]
|
|
|
|
|
|
Y Y Leung, K M Lo, L S Tam, C C Szeto, E K Li, and E W Kun Estimation of glomerular filtration rate in patients with systemic lupus erythematosus Lupus, May 1, 2006; 15(5): 276 - 281. [Abstract] [PDF]
|
|
|
|
|
|
R Prasad, D Ibanez, D Gladman, and M Urowitz Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus Lupus, May 1, 2006; 15(5): 285 - 291. [Abstract] [PDF]
|
|
|
|
|
|
K. P. Leong, K. O. Kong, B. Y. H. Thong, E. T. Koh, T. Y. Lian, C. L. Teh, Y. K. Cheng, H. H. Chng, H. Badsha, W. G. Law, et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL) Rheumatology, October 1, 2005; 44(10): 1267 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Ruiz-Irastorza, M-V Egurbide, A Martinez-Berriotxoa, J Ugalde, and C Aguirre Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus Lupus, December 1, 2004; 13(12): 900 - 905. [Abstract] [PDF]
|
|
|
|
|
|
J. Mikdashi and B. Handwerger Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort Rheumatology, December 1, 2004; 43(12): 1555 - 1560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Stoll, N. Sutcliffe, J. Mach, R. Klaghofer, and D. A. Isenberg Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study Rheumatology, August 1, 2004; 43(8): 1039 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Alarcon, J. M. Roseman, G. McGwin Jr, A. Uribe, H. M. Bastian, B. J. Fessler, B. A. Baethge, A. W. Friedman, and J. D. Reveille Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage Rheumatology, February 1, 2004; 43(2): 202 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Isenberg, E. Allen, V. Farewell, M. R. Ehrenstein, M. G. Hanna, I. E. Lundberg, C. Oddis, C. Pilkington, P. Plotz, D. Scott, et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease Rheumatology, January 1, 2004; 43(1): 49 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Soares, L Reis, J A. Papi, and C R. Cardoso Rate, pattern and factors related to damage in Brazilian systemic lupus erythematosus patients Lupus, October 1, 2003; 12(10): 788 - 794. [Abstract] [PDF]
|
|
|
|
|
|
C.-S. Yee, H. Hussein, J. Skan, S. Bowman, D. Situnayake, and C. Gordon Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus Rheumatology, February 1, 2003; 42(2): 276 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Manger, B Manger, R Repp, M Geisselbrecht, A Geiger, A Pfahlberg, T Harrer, and J R Kalden Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus Ann Rheum Dis, December 1, 2002; 61(12): 1065 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gordon Long-term complications of systemic lupus erythematosus Rheumatology, October 1, 2002; 41(10): 1095 - 1100. [Full Text] [PDF]
|
|
|
|
|
|
Y Molad, A Gorshtein, A J Wysenbeek, D Guedj, R Majadla, A Weinberger, and M Amit-Vazina Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort{ Lupus, June 1, 2002; 11(6): 356 - 361. [Abstract] [PDF]
|
|
|
|
|
|
A. S. Wilson, G. D. Kitas, D. M. Carruthers, C. Reay, J. Skan, S. Harris, G. J. Treharne, S. P. Young, and P. A. Bacon Computerized information-gathering in specialist rheumatology clinics: an initial evaluation of an electronic version of the Short Form 36 Rheumatology, March 1, 2002; 41(3): 268 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Stoll, Y. Kauer, S. Buchi, R. Klaghofer, T. Sensky, and P. M. Villiger Prediction of depression in systemic lupus erythematosus patients using SF-36 Mental Health scores Rheumatology, June 1, 2001; 40(6): 695 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Rahman, D D Gladman, M B Urowitz, D Hallett, and L S Tam Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus Lupus, February 1, 2001; 10(2): 93 - 96. [Abstract] [PDF]
|
|
|
|
|
|
N. Sutcliffe, A. E. Clarke, R. Taylor, C. Frost, and D. A. Isenberg Total costs and predictors of costs in patients with systemic lupus erythematosus Rheumatology, January 1, 2001; 40(1): 37 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Stoll, N. Sutcliffe, R. Klaghofer, and D. A Isenberg Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage?: a prospective study Ann Rheum Dis, October 1, 2000; 59(10): 832 - 835. [Abstract] [Full Text]
|
|
|
|
|
|
G M Devins, S M Edworthy, and the ARAMIS Lupus State Models Research Group Illness intrusiveness explains race-related quality-of-life differences among women with systemic lupus erythematosus Lupus, September 1, 2000; 9(7): 534 - 541. [Abstract] [PDF]
|
|
|
|
|
|
V Strand, D Gladman, D Isenberg, M Petri, J Smolen, and P Tugwell Endpoints: consensus recommendations from OMERACT IV Lupus, June 1, 2000; 9(5): 322 - 327. [Abstract] [PDF]
|
|
|
|
|
|
J Thumboo, H-Y Lee, K-Y Fong, S-P Chan, C. Chapman, K-H Leong, P-H Feng, S-T Thio, and M-L Boey Accuracy of medical record scoring of the SLICC/ACR Damage Index for systemic lupus erythematosus Lupus, June 1, 2000; 9(5): 358 - 362. [Abstract] [PDF]
|
|
|
|
|
|
S Buchi, P Villiger, Y Kauer, R Klaghofer, T Sensky, and T Stoll PRISM (Pictorial Representation of Illness and Self Measure) - a novel visual method to assess the global burden of illness in patients with systemic lupus erythematosus Lupus, June 1, 2000; 9(5): 368 - 373. [Abstract] [PDF]
|
|
|
|
|
|
C. C. Mok, K. W. Lee, C. T. K. Ho, C. S. Lau, and R. W. S. Wong A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population Rheumatology, April 1, 2000; 39(4): 399 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Urowitz and D. D. Gladman How to improve morbidity and mortality in systemic lupus erythematosus Rheumatology, March 1, 2000; 39(3): 238 - 244. [Full Text] [PDF]
|
|
|
|
|
|
D. Isenberg and R. Ramsey-Goldman Assessing patients with lupus: towards a drug responder index Rheumatology, November 1, 1999; 38(11): 1045 - 1049. [Full Text] [PDF]
|
|
|
|
|
|
N. Sutcliffe, A. E. Clarke, C. Gordon, V. Farewell, and D. A. Isenberg The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus Rheumatology, November 1, 1999; 38(11): 1130 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Schneider Response and remission criteria for clinical trials in lupus-- what can we learn from other diseases? Lupus, October 1, 1999; 8(8): 627 - 631. [PDF]
|
|
|
|
|
|
D D Gladman and M. B Urowitz The SLICC/ACR damage index: progress report and experience in the field Lupus, October 1, 1999; 8(8): 632 - 637. [Abstract] [PDF]
|
|
|
|
|
|
J Thumboo, K-Y Fong, S-P Chan, K-H Leong, P-H Feng, S-T Thio, and M-L Boey Validation of the medical outcomes study family and marital functioning measures in SLE patients in Singapore Lupus, September 1, 1999; 8(7): 514 - 520. [Abstract] [PDF]
|
|
|
|
|
|
A Zonana-Nacach, A Camargo-Coronel, P Yanez, M de Lourdes Sanchez, F J Jaimenez-Balderas, J Aceves-Avila, P Martinez-Osuna, J Fuentes, F Medina, and A Fraga Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration Lupus, February 1, 1998; 7(2): 119 - 123. [Abstract] [PDF]
|
|
|
|
|
|
T. Stoll, G. Stucki, C. Gordon, and D.A. Isenberg A Damage Index for Lupus Patients -- Where are we now? Lupus, January 1, 1997; 6(3): 219 - 222. [PDF]
|
|